Joerg J Schneider

By Louis Cicchini, Ph.D., Michael Day, Ph.D., and Joerg Schneider, Ph.D., Cencora Understanding the divergent regulatory standards between international markets is critical for therapy developers. Recent updates to European pharmaceutical legislation now redefine genome editing techniques, while new supply requirements introduce logistical hurdles for personalized therapies.

Molybdenum(VI) oxide (MoO3) nanorod arrays were synthesized employing a template-assisted method. A polycarbonate membrane as template was vacuum infiltrated by an aqueous solution of ammonium heptamolybdate. Template removal by oxygen plasma etching and calcination lead to the formation of highly crystalline 3D MoO3 nanorod arrays as negative replica of the template. Applying sucrose as carbon precursor, a mantling of the MoO3 nanorods with a thin carbon coat is obtained.

Multi-layer heterostructure oxide semiconductors employing a layer-by-layer deposition of alternating indium oxide and zinc oxide thin films generated via atomic layer deposition (ALD) are investigated for their feasibility into high performance thin film transistors (TFT). The successful deposition of uniform film thickness across the alternating indium oxide and zinc oxide deposition at 200°C is achieved using trimethyl indium (TMI), diethyl zinc (DEZ) and water as oxidizing agent.